Logiscreen

QuidelOrtho Corporation

$16.67
Market Cap 1.13B
ROE -56.3%
Gross Margin 42.6%
Debt/Equity 1.5
Current Ratio 1.4
Revenue QoQ -10.5%
EPS QoQ 6.1%
F-Score 1

About

With expertise spanning clinical chemistry, immunoassay, immunohematology and molecular testing, QuidelOrtho Corporation is a leading global provider of diagnostic solutions, dedicated to advancing fast, accurate and reliable results that help improve patient outcomes – from the point of care to hospital, lab to clinic. Building on a legacy of innovation, QuidelOrtho works with healthcare providers to advance diagnostics that connect insights with solutions, defining a clearer path for informed decisions and better care.

Exchange
NASDAQ
Sector
Healthcare
Industry
Medical Devices

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-1.03
vs median 36.93
P/B
0.67
vs median 2.32
ROE
-0.56
vs median 0.09

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics